Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Psychiatry Res
    November 2025
  1. HOWIE JH, Fielden CR, Rempfer MV
    Cognition in schizophrenia across phases of illness: A systematic review and meta-analysis.
    Psychiatry Res. 2025;355:116856.
    >> Share

  2. SAKA IM, Arslan FC, Demir S, Mentese A, et al
    The relationship between serum Interleukin- 6, Interleukin- 18, Interleukin- 2, Eotaxin-1, Monocyte Chemoattractant Protein 1 levels and cognitive functions in treatment-resistant schizophrenia.
    Psychiatry Res. 2025;355:116835.
    >> Share

  3. SUN A, Eakins RE, Gozlan EC, Chobrutskiy A, et al
    A quantitative assessment of TRB CDR3-CMV antigen chemical interactions distinguishes schizophrenia patients in case/control comparisons.
    Psychiatry Res. 2025;355:116834.
    >> Share

  4. MIZUTANI R, Saiga R, Yamamoto Y, Inomoto C, et al
    Pyramidal soma size in the anterior cingulate cortex is small in schizophrenia and correlates with hallucination score.
    Psychiatry Res. 2025;355:116822.
    >> Share

  5. CELIC RUZIC M, Zarkovic N, Rossini Gajsak L, Filipcic I, et al
    Persistent oxidative stress and functional outcomes in early psychosis: A longitudinal study.
    Psychiatry Res. 2025;354:116818.
    >> Share

    October 2025
  6. GUO X, Wu S, Jia T, Sun Z, et al
    Plasma fatty acids levels and risk of schizophrenia in the UK Biobank: a prospective cohort study.
    Psychiatry Res. 2025;354:116805.
    >> Share

  7. VERDAGUER-RODRIGUEZ M, Lopez-Carrilero R, Diaz-Cutraro L, Ferrer-Quintero M, et al
    Sex-based differences in neurocognitive functioning in first-episode psychosis: An exploratory analysis.
    Psychiatry Res. 2025;354:116803.
    >> Share

  8. DELISI LE
    Reflections from half a century of progress searching for the causes of schizophrenia: Stanley Dean award presentation 2025.
    Psychiatry Res. 2025;354:116790.
    >> Share

  9. HU G, Wei D, Zhang J, Liu J, et al
    Effect of computerized cognitive remediation therapy combined with individualized occupational therapy on cognitive function and functional outcomes in patients with schizophrenia: A randomized controlled trial.
    Psychiatry Res. 2025;354:116789.
    >> Share

  10. ZENCIR T, Celik Zencir A, Tekinarslan G, Koc M, et al
    The role of socioeconomic and structural vulnerability risk factors in employment outcomes for individuals with Schizophrenia and other psychotic disorders.
    Psychiatry Res. 2025;354:116782.
    >> Share

  11. LEIJALA J, Kampman O, Gunnar T, Suvisaari J, et al
    Treatment adherence in first-episode psychosis: A one-year follow-up study comparing self-reported adherence, pharmacy refill data, and therapeutic drug monitoring.
    Psychiatry Res. 2025;354:116780.
    >> Share

  12. MUELLER N, Mulfarth R, Seuffert S, Dannlowski U, et al
    Figurative language production in schizophrenia, bipolar disorder, and depression.
    Psychiatry Res. 2025;354:116772.
    >> Share

  13. ASENJO-LOBOS C, Arancibia M, Garcia-Ribera C, Cortes-Jofre M, et al
    Comparative efficacy and safety of Clozapine vs. Quetiapine in schizophrenia and related disorders: An updated systematic review.
    Psychiatry Res. 2025;353:116764.
    >> Share

  14. PREOBRAZENSKI N, Hsieh T, Robertson C, Thai H, et al
    Polypharmacy in clozapine-treated patients: A retrospective analysis of 667 patients in Ottawa, Canada.
    Psychiatry Res. 2025;352:116684.
    >> Share

  15. XUE J, Zhai Z, Li X, Zhu Y, et al
    Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial.
    Psychiatry Res. 2025;353:116756.
    >> Share

    September 2025
  16. PANGANIBAN KJ, Smith ECC, Stogios N, Agarwal SM, et al
    The cognitive metabolomic signatures in schizophrenia spectrum disorders: A systematic review.
    Psychiatry Res. 2025;353:116742.
    >> Share

  17. MONTI P, Iodice S, Capuzzi E, Borroni E, et al
    Short-term exposure to particulate matter and apparent temperature is associated with schizophrenia severity in Italy.
    Psychiatry Res. 2025;353:116735.
    >> Share

  18. SOTERO-MORENO A, Guardiola-Ripoll M, Hostalet N, Moreira M, et al
    Effects of DISC1 and hypoxia-sensitive genes on dermatoglyphics and cognitive function in schizophrenia.
    Psychiatry Res. 2025;353:116721.
    >> Share

  19. BIAGETTI R, Caiazza L, Giuva T, Pirani G, et al
    Clozapine-induced cardiac toxicity and successful rechallenge in children and adolescents: a systematic review and new case report.
    Psychiatry Res. 2025;351:116646.
    >> Share

  20. GOMBAS SA, Moran EK, Barch DM
    Relationships between cognition and symptoms across mood and psychotic disorders.
    Psychiatry Res. 2025;351:116628.
    >> Share

  21. ZHU T, Jiao X, Zhou J, Nicholas PJ, et al
    Efficacy of rTMS on SCZ symptoms: Insights from connectome mapping.
    Psychiatry Res. 2025;351:116568.
    >> Share

  22. LU N, Wang M, Zheng Z, Zhang F, et al
    Comorbidity of common psychiatric disorders and attention-deficit/hyperactivity disorder in Chinese adults.
    Psychiatry Res. 2025;351:116662.
    >> Share

    August 2025
  23. PATEL SES, Haut KM, Lee H, Fisher M, et al
    Social cognition training improves recognition of individual emotions in schizophrenia disorder.
    Psychiatry Res. 2025;352:116711.
    >> Share

  24. BLAIN SD, Kent JS, Peyromaure de Bord CA, Sponheim SR, et al
    Social cognitive deficits in schizophrenia, bipolar disorder, and first-degree relatives: A large-sample, multi-task investigation.
    Psychiatry Res. 2025;352:116694.
    >> Share

  25. JUST SA, Elvevag B, Pandey S, Nenchev I, et al
    Moving beyond word error rate to evaluate automatic speech recognition in clinical samples: Lessons from research into schizophrenia-spectrum disorders.
    Psychiatry Res. 2025;352:116690.
    >> Share

  26. WANG Z, Li J, Wang L, Wei Q, et al
    Comparative Effects of Exercise Modalities on Negative Symptoms in Schizophrenia: A Systematic Review and Network Meta-analysis of 32 RCTs.
    Psychiatry Res. 2025;352:116665.
    >> Share

  27. ASENJO-LOBOS C, Arancibia M, Cortes-Jofre M, Huang T, et al
    Comparative efficacy and safety of clozapine vs. risperidone in schizophrenia and related disorders: An updated systematic review.
    Psychiatry Res. 2025;351:116670.
    >> Share

    July 2025
  28. DUDLEY R, White S, Miskin R, Oakes L, et al
    Corrigendum to Hallucinations across sensory domains in people with post-traumatic stress disorder and psychosis, Psychiatry Research, Vol 342, December 2024, 116229.
    Psychiatry Res. 2025;351:116642.
    >> Share

  29. ARSLAN B, Kizilay E, Turan YE, Verim B, et al
    Computational linguistic investigation in schizophrenia and autism spectrum disorders.
    Psychiatry Res. 2025;351:116633.
    >> Share

  30. LEATHEM LD, Barch DM, Moran EK, Patel PK, et al
    Cognitive effort-based decision making in schizophrenia and bipolar disorder: Associations with clinical symptoms and cognitive performance.
    Psychiatry Res. 2025;351:116629.
    >> Share

  31. CHIU EC, Lee SC
    Effect of community-based reablement program on quality of life for people with schizophrenia: A randomized controlled study.
    Psychiatry Res. 2025;351:116624.
    >> Share

    June 2025
  32. STUDART I, Rasmussen AR
    OCD with psychotic features or schizophrenia with obsessions and compulsions?
    Psychiatry Res. 2025;351:116619.
    >> Share

  33. SUN X, Qiu Y, Ji L, Li M, et al
    Proteomic characterization of plasma exosomes in drug-naive schizophrenia: Insights into psychosis and cognitive dysfunction.
    Psychiatry Res. 2025;351:116611.
    >> Share

  34. SU Q, Wang J, Ge H, Li M, et al
    The relationship between inflammation and cognitive function in drug-naive schizophrenia with or without pre-metabolic syndrome.
    Psychiatry Res. 2025;351:116604.
    >> Share

  35. KOTWANI A, Wojtalik JA, Gunzler DD, Smith MJ, et al
    Social cognition as a mediator between neurocognition and functional outcome in early course schizophrenia.
    Psychiatry Res. 2025;351:116594.
    >> Share

  36. JACOBSEN SL, Kohler-Forsberg O, Danielsen AA, Rohde C, et al
    Efficacy and safety of GLP1-ras compared to SGLT2is and DPP-4is in individuals with schizophrenia and diabetes: A Danish nationwide target-trial emulation study.
    Psychiatry Res. 2025;351:116592.
    >> Share

  37. AL-KURAISHY HM, Mohammed HA, Sulaiman GM, Jabir MS, et al
    Targeting of inflammation and prostaglandins by nonsteroidal anti-inflammatory drugs in schizophrenia: A narrative review.
    Psychiatry Res. 2025;351:116575.
    >> Share

    May 2025
  38. PILON F, Boisvert M, Mottron L, Potvin S, et al
    A fMRI meta-analysis of emotion processing in the psychosis spectrum reveals no significant alterations in at-risk individuals.
    Psychiatry Res. 2025;351:116565.
    >> Share

  39. DODGSON G, Singh A, Barclay N, Birkett L, et al
    Managing unusual sensory experiences in at-risk mental state for psychosis in England: A parallel group, single-blind, randomised controlled feasibility trial.
    Psychiatry Res. 2025;351:116564.
    >> Share

  40. SAITOH K, Lajnef M, Boukouaci W, Andre M, et al
    Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort.
    Psychiatry Res. 2025;350:116557.
    >> Share

  41. CHEN B, Tan XW, Tor PC
    Effects of dose on early treatment response to bifrontal electroconvulsive therapy in Schizophrenia: A retrospective study.
    Psychiatry Res. 2025;350:116554.
    >> Share

  42. CORONADO-MONTOYA S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, et al
    A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis.
    Psychiatry Res. 2025;350:116553.
    >> Share

  43. TOTZEK JF, Shah JL, Young AL, Malla A, et al
    From resting-state functional hippocampal centrality to functional outcome: An extended neurocognitive model of psychosis.
    Psychiatry Res. 2025;350:116538.
    >> Share

  44. GUTIERREZ G, Garcia de Jalon E, Aranguren L, Corrales A, et al
    Corrigendum to 'Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study' [ Psychiatry Research volume 342 (December 2024) 1-10/116261].
    Psychiatry Res. 2025 May 16:116539. doi: 10.1016/j.psychres.2025.116539.
    >> Share

  45. LUO H, Li YL, Luo XJ, Xia L, et al
    The efficacy of psychoeducation-based programs on internalized stigma in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2025;350:116540.
    >> Share

  46. HOFMANN AB, Dorner M, Klassen PE, Machetanz L, et al
    RIPTOSO: The development of a screening tool for adverse events during forensic-psychiatric inpatient treatments of offenders with schizophrenia spectrum disorders.
    Psychiatry Res. 2025;350:116537.
    >> Share

  47. BERE M, Rossell SL, Toh WL
    Corrigendum to Cognition in relation to non-auditory or multisensory hallucinations in schizophrenia-spectrum disorders: A scoping review.
    Psychiatry Res. 2025;349:116526.
    >> Share

  48. PERALTA V, de Jalon EG, Moreno-Izco L, Peralta D, et al
    Corrigendum to 'A clinical staging model of psychotic disorders based on a long-term follow-up of first-admission psychosis: A validation study' Psychiatry Res. 2023; 322:115109.
    Psychiatry Res. 2025;349:116530.
    >> Share

    April 2025
  49. DEMIRLI E, Ahmed AO, Serper M
    Personal recovery and future self-continuity in individuals with schizophrenia.
    Psychiatry Res. 2025;348:116510.
    >> Share

  50. PELIZZA L, Leuci E, Quattrone E, Palmisano D, et al
    Compulsory admission as access to early intervention service for patients with first episode psychosis: What relevance for clinical outcomes? Further findings from the Pr-EP program.
    Psychiatry Res. 2025;349:116507.
    >> Share

  51. SALGADO-PINEDA P, Barbosa L, Hostalet N, Garcia-Leon MA, et al
    An ontogenetic role for Broca's and related speech areas in schizophrenic auditory hallucinations? Evidence from sulcal pits analysis.
    Psychiatry Res. 2025;348:116502.
    >> Share

  52. CAO C, Liu W, Hou C, Chen Y, et al
    Disrupted default mode network connectivity and its role in negative symptoms of schizophrenia.
    Psychiatry Res. 2025;348:116489.
    >> Share

  53. LU J, Gou N, Zhang S, Zhou J, et al
    Dysfunctional striatal-temporal connectivity is associated with a higher risk for violence in patients with schizophrenia.
    Psychiatry Res. 2025;348:116488.
    >> Share

    March 2025
  54. SIMGE UO, Burcu V, Aybuke K, Ezgi C, et al
    Clinical high risk for psychosis in bipolar disorder: Clinical features, cognition and functioning.
    Psychiatry Res. 2025;348:116478.
    >> Share

  55. SHAKER NM, Aly El-Gabry D, Abdel Aziz K, Hashem R, et al
    Clinical and neuroradiological differences in obsessive compulsive disorder with and without psychosis.
    Psychiatry Res. 2025;348:116472.
    >> Share

  56. KANE JM, Rubio JM, Casciano J, Dotiwala Z, et al
    Real-world outcomes and practice patterns among patients with schizophrenia when switched from oral antipsychotics to long-acting injectable formulations after hospitalization.
    Psychiatry Res. 2025;348:116455.
    >> Share

  57. APRILE SF, Rodolico A, Di Francesco A, Varrasi S, et al
    Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients' subjective experiences.
    Psychiatry Res. 2025;348:116460.
    >> Share

  58. LINDSTROM S, Nordgaard J, Berge J
    Transition from schizotypal disorder to non-affective psychotic disorders including schizophrenia: A nationwide Swedish cohort study.
    Psychiatry Res. 2025;348:116470.
    >> Share

  59. BAILEY A, Bauer BW, Mittal VA, Ellman LM, et al
    Interpersonal difficulties and suicidal ideation in young people at clinical high-risk for psychosis and help-seeking clinical controls.
    Psychiatry Res. 2025;348:116467.
    >> Share

  60. NEERGAARD KD, Zemla JC, Victor Ortiz-Garcia de la F, Lubrini G, et al
    Novel computational measure of semantic fluency performance associated with first-episode of psychosis.
    Psychiatry Res. 2025;348:116462.
    >> Share

  61. SUDAR FP, Zekerallah SS, Paulzen M, Mathiak K, et al
    Unraveling antipsychotic induced weight gain in schizophrenia - A proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychotics.
    Psychiatry Res. 2025;348:116452.
    >> Share

  62. SHIMADA T, Ito S, Yamanushi A, Koizumi A, et al
    Effect of aerobic exercise versus cognitive remediation versus a combination of both on cognition among patients with schizophrenia: A three-arm, randomized controlled study.
    Psychiatry Res. 2025;348:116454.
    >> Share

  63. GOLDSTEIN KE, Pietrzak RH, Aladin S, Ng S, et al
    Neuro- and social-cognition in schizotypal personality disorder and schizophrenia: A spectrum of severity.
    Psychiatry Res. 2025;348:116445.
    >> Share

  64. MEWENGKANG A, Pandolos T, Sengkey MM, Sengkey SB, et al
    Sleep quality vs. mental health: A complex relationship with psychosis.
    Psychiatry Res. 2025;348:116441.
    >> Share

  65. SENTHIL KUMAR L, Chen B, Tan X, Tor PC, et al
    Response to electroconvulsive therapy is not consistently replicated across multiple treatment courses.
    Psychiatry Res. 2025;345:116374.
    >> Share

  66. LOHMAN MC, Scott V, Verma M, Jones P, et al
    Distribution and correlates of long-acting injectable antipsychotic use among community mental health center patients.
    Psychiatry Res. 2025;345:116378.
    >> Share

    February 2025
  67. SOLBERG A, Ottesen A, Barrett EA, Kristiansen I, et al
    Trajectories of suicidal behavior and their clinical correlates in the early phases of schizophrenia spectrum disorders.
    Psychiatry Res. 2025;347:116409.
    >> Share

  68. DAMIANI S, D'Imperio A, Radua J, Fortea L, et al
    A systematic review and synthesis of 489 studies investigating treatments for negative symptoms in the schizophrenia spectrum: Trial designs, demographics and clinical characteristics.
    Psychiatry Res. 2025;347:116406.
    >> Share

  69. CAI C, Zhao P, Patel C, Benson C, et al
    Latent variable analysis of adherence to antipsychotics among south carolina medicaid beneficiaries with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2025;346:116402.
    >> Share

  70. HANDEST R, Molstrom IM, Henriksen MG, Nordgaard J, et al
    Revisiting the relationship between impaired social functioning and psychopathology in schizophrenia.
    Psychiatry Res. 2025;346:116389.
    >> Share

    January 2025
  71. HUIZER K, Soni S, Schmidt MA, Cakici N, et al
    Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia.
    Psychiatry Res. 2025;345:116379.
    >> Share

  72. HWANG H, Kim SM, Kim HJ, Han DH, et al
    Comparison of attention and brain functional connectivity between patient groups with schizophrenia and attention deficit hyperactivity disorder.
    Psychiatry Res. 2025;345:116376.
    >> Share

  73. BERISHA F, Paquin V, Gold I, Misic B, et al
    Exploring delusional themes and other symptoms in first episode psychosis: A network analysis over two timepoints.
    Psychiatry Res. 2025;344:116349.
    >> Share

  74. GRENDAS LN, Olaviaga A, Chiapella LC, Daray FM, et al
    Incidence rate of suicidal behavior stratified by diagnosis among high-risk patients.
    Psychiatry Res. 2025;343:116310.
    >> Share

    December 2024
  75. LI J, He J, Ren H, Li Z, et al
    Multilayer network instability underlying persistent auditory verbal hallucinations in schizophrenia.
    Psychiatry Res. 2024;344:116351.
    >> Share

  76. ZHANG H, He R, Palominos C, Hsu N, et al
    The structure of meaning in schizophrenia: A study of spontaneous speech in Chinese.
    Psychiatry Res. 2024;344:116347.
    >> Share

  77. HSIAO CY, Wu KY, Chiu CK, Lu HL, et al
    Development and validation of a schizophrenia literacy scale for individuals diagnosed with schizophrenia.
    Psychiatry Res. 2024;344:116344.
    >> Share

  78. PIETERS LE, Deenik J, Hoogendoorn AW, van Someren EJW, et al
    Sleep and physical activity patterns in relation to daily-life symptoms in psychosis: An actigraphy and experience sampling study.
    Psychiatry Res. 2024;344:116320.
    >> Share

  79. GARCIA-FERNANDEZ L, Romero-Ferreiro V, Padilla S, Wynn R, et al
    Transcranial direct current stimulation (tDCS) enhances cognitive function in schizophrenia: A randomized double-blind sham-controlled trial.
    Psychiatry Res. 2024;344:116308.
    >> Share

  80. WYSOKINSKI A, Dreczka J
    Clozapine Toxicity Predictor: Deep neural network model predicting clozapine toxicity and its therapeutic dose range.
    Psychiatry Res. 2024;342:116256.
    >> Share

  81. SOLDEVILA-MATIAS P, Sanchez-Orti JV, Correa-Ghisays P, Balanza-Martinez V, et al
    Exercise as a promoter of neurocognitive improvement in people with psychiatric disorders and comorbid obesity: A randomized controlled trial.
    Psychiatry Res. 2024;342:116226.
    >> Share

  82. FLORENTIN S, Neumark Y, Roe D, Rosca P, et al
    The relationship between community-based psychiatric rehabilitation pathways and re-hospitalization trajectories: A three-decade follow-up.
    Psychiatry Res. 2024;342:116216.
    >> Share

  83. PISANU C, Congiu D, Meloni A, Paribello P, et al
    Sex differences in shared genetic determinants between severe mental disorders and metabolic traits.
    Psychiatry Res. 2024;342:116195.
    >> Share

    November 2024
  84. SOURANDER A, Silwal S, Surcel HM, Hinkka-Yli-Salomaki S, et al
    Maternal vitamin B12 during pregnancy and schizophrenia in offspring.
    Psychiatry Res. 2024;344:116284.
    >> Share

  85. MORITZ S, Leucht S, Hoyer L, Schmotz S, et al
    Towards the DSM-6: The intersection of OCD and psychosis. Expert perspectives on insight in the diagnosis of OCD.
    Psychiatry Res. 2024;344:116306.
    >> Share

  86. KHOODORUTH MAS, Hussain T, Ouanes S, Chut-Kai Khoodoruth NW, et al
    Peripheral inflammatory and metabolic markers as potential biomarkers in treatment-resistant schizophrenia: Insights from a Qatari Cohort.
    Psychiatry Res. 2024;344:116307.
    >> Share

  87. KUMAR M, Choudhary H, Chawla N
    Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study: Letter to the editor.
    Psychiatry Res. 2024;343:116299.
    >> Share

  88. GONCALVES CC, Waters Z, Quirk SE, Haddad PM, et al
    Barriers and facilitators to mental health care access and engagement for LGBTQA+ people with psychosis: A scoping review.
    Psychiatry Res. 2024;343:116281.
    >> Share

  89. REANGSING C, Wongsuraprakit S, Punsuwun S, Oerther S, et al
    Effects of mindfulness-based interventions (MBIs) on psychotic symptoms and psychological outcomes in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Psychiatry Res. 2024;342:116272.
    >> Share

  90. LAMARCA M, Espinosa V, Acuna V, Vila-Badia R, et al
    Reducing self-stigma in psychosis: A systematic review and meta-analysis of psychological interventions.
    Psychiatry Res. 2024;342:116262.
    >> Share

  91. BERE M, Rossell SL, Toh WL
    Cognition in relation to non-auditory or multisensory hallucinations in schizophrenia-spectrum disorders: A scoping review.
    Psychiatry Res. 2024;342:116268.
    >> Share

  92. ABRAHAM T, Gill H, Wood L
    Psychosocial interventions offered across inpatient and crisis settings to the social networks of service users with psychosis: A systematic review.
    Psychiatry Res. 2024;343:116267.
    >> Share

  93. GUTIERREZ G, Garcia de Jalon E, Aranguren L, Corrales A, et al
    Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study.
    Psychiatry Res. 2024;342:116261.
    >> Share

  94. PUGH SL, Chandler C, Cohen AS, Diaz-Asper C, et al
    Assessing dimensions of thought disorder with large language models: The tradeoff of accuracy and consistency.
    Psychiatry Res. 2024;341:116119.
    >> Share

    October 2024
  95. CALZAVARA PINTON I, Nibbio G, Bertoni L, Cicale A, et al
    The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study.
    Psychiatry Res. 2024;342:116240.
    >> Share

  96. DEMIRLEK C, Verim B, Zorlu N, Demir M, et al
    Functional brain networks in clinical high-risk for bipolar disorder and psychosis.
    Psychiatry Res. 2024;342:116251.
    >> Share

  97. KISIANG'ANI IB, Aden M, Mwangi HR, Akena D, et al
    Exploring psychotic symptoms among substance-naive individuals and recent abstainers without a psychosis diagnosis: A cross-country study across Kenya, Uganda, Ethiopia, and South Africa.
    Psychiatry Res. 2024;342:116253.
    >> Share

  98. THIBAUDEAU E, Bowie CR, Montreuil T, Baer L, et al
    Acceptability, engagement, and efficacy of cognitive remediation for cognitive outcomes in young adults with first-episode psychosis and social anxiety: A randomized-controlled trial.
    Psychiatry Res. 2024;342:116243.
    >> Share

  99. GONZALES L, Saperstein AM, Qian M, Gorecki A, et al
    Psychiatric and functional correlates of stigma associated with cognitive impairment in schizophrenia.
    Psychiatry Res. 2024;342:116233.
    >> Share

  100. CIOFFI L, Wein PY, Miller SA, Fagan S, et al
    Clinical, neurocognitive, neurobiological and functional correlates of sleep difficulties in individuals at-risk for psychosis and mania: A scoping review.
    Psychiatry Res. 2024;342:116235.
    >> Share

  101. DUDLEY R, White S, Miskin R, Oakes L, et al
    Hallucinations across sensory domains in people with post-traumatic stress disorder and psychosis.
    Psychiatry Res. 2024;342:116229.
    >> Share

  102. TORREY EF, Simmons W, Dailey L
    Schizophrenia, clinical and basic research at NIMH: A 75 Year retrospective.
    Psychiatry Res. 2024;342:116225.
    >> Share

  103. SARNYAI Z, Ben-Shachar D
    Schizophrenia, a disease of impaired dynamic metabolic flexibility: A new mechanistic framework.
    Psychiatry Res. 2024;342:116220.
    >> Share

  104. BERA S, Yang AB, Chung D, Arnesen R, et al
    Duffy-null associated neutrophil count and antipsychotic use.
    Psychiatry Res. 2024;340:116146.
    >> Share

    September 2024
  105. ARMARIO A, Nadal R, Fuentes S, Visa J, et al
    Prenatal immune activation in rats and adult exposure to inescapable shocks reveal sex-dependent effects on fear conditioning that might be relevant for schizophrenia.
    Psychiatry Res. 2024;342:116219.
    >> Share

  106. GIAMPETRUZZI E, Walker EF, Addington J, Bearden CE, et al
    Impact of adverse childhood experiences on risk for internalizing psychiatric disorders in youth at clinical high-risk for psychosis.
    Psychiatry Res. 2024;342:116214.
    >> Share

  107. TEYMOURI K, Ebrahimi M, Chen CC, Sriretnakumar V, et al
    Sex-dependent association study of complement C4 gene with treatment-resistant schizophrenia and hospitalization frequency.
    Psychiatry Res. 2024;342:116202.
    >> Share

  108. SUKNO FM, Kelly BD, Lane A, Katina S, et al
    Loss of normal facial asymmetry in schizophrenia and bipolar disorder: Implications for development of brain asymmetry in psychotic illness.
    Psychiatry Res. 2024;342:116213.
    >> Share

  109. CIUFALO J, Zaccone S, Fatiga G, Caputo GB, et al
    Creative puppet therapy reduces hallucinations in patients diagnosed with schizophrenia: Preliminary findings.
    Psychiatry Res. 2024;342:116211.
    >> Share

  110. GLINERT A, Zlidennyy V, Turjeman S, Sharon E, et al
    What's GABA got to do with it? A potential link between the microbiome, schizophrenia, and the endo-cannabinoid system.
    Psychiatry Res. 2024;342:116196.
    >> Share

  111. DOMINGUEZ T, Puebla DP, Fresan A, Sheinbaum T, et al
    Why do some Mexicans with psychosis risk symptoms seek mental health care and others do not?
    Psychiatry Res. 2024;342:116199.
    >> Share

  112. CASANOVAS F, Dinamarca F, Posso M, Mane A, et al
    Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis.
    Psychiatry Res. 2024;342:116206.
    >> Share

  113. MEHTA UM, Roy N, Bahuguna A, Kotambail A, et al
    Incremental predictive value of genetic risk and functional brain connectivity in determining antipsychotic response in schizophrenia.
    Psychiatry Res. 2024;342:116201.
    >> Share

  114. TANG JMY, Chiu KKY, Yang C, Cheung DSK, et al
    Social cognition interventions for patients with first-episode psychosis: A scoping review.
    Psychiatry Res. 2024;342:116191.
    >> Share

  115. KRISTENSEN TD, Mager FM, Ambrosen KS, Barber AD, et al
    Cognitive profiles across the psychosis continuum.
    Psychiatry Res. 2024;342:116168.
    >> Share

  116. D'ANDREA G, Ouellet-Plamondon C, Villeneuve M, Shah JL, et al
    Joint-trajectories of clinical severity, social functioning and cannabis use in first-episode psychosis: A 5-year longitudinal study in 2 urban early intervention services.
    Psychiatry Res. 2024;342:116184.
    >> Share

  117. VALT C, Lopez-Caballero F, Tavella A, Altamura M, et al
    Abnormal inter-hemispheric effective connectivity from left to right auditory regions during Mismatch Negativity (MMN) tasks in psychosis.
    Psychiatry Res. 2024;342:116189.
    >> Share

  118. BORNHEIMER LA, Bagge CL, Overholser J, Brdar NM, et al
    Demographic and clinical characteristics of individuals with psychosis symptoms who died by suicide: Findings of a psychological autopsy study.
    Psychiatry Res. 2024;342:116185.
    >> Share

  119. HSIEH KP, Liao WL, Ho PS, Lin JW, et al
    Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study.
    Psychiatry Res. 2024;342:116171.
    >> Share

  120. DE HAAS HJ, Cohen D, de Koning MB, van Weringh G, et al
    Clozapine levels and outcomes in Serbian patients with treatment-resistant psychotic disorders previously treated without measuring clozapine levels (CLOSER).
    Psychiatry Res. 2024;339:116070.
    >> Share

  121. PICCHIONI M, Ruiz R, de Girolamo G, Iozzino L, et al
    The predictive validity and temporal characteristics of the HCR-20v3 for inpatient violence in forensic inpatient settings. An international study.
    Psychiatry Res. 2024;339:116079.
    >> Share

  122. ZACHOS KA, Choi J, Godin O, Chernega T, et al
    Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder.
    Psychiatry Res. 2024;339:116063.
    >> Share

  123. LUYKX JJ, Tanskanen A, Lahteenvuo M, Manu P, et al
    Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking.
    Psychiatry Res. 2024;339:116012.
    >> Share

    August 2024
  124. MORKVED N, Johnsen E, Kroken RA, Joa I, et al
    Childhood trauma types in relation to antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, randomized controlled study.
    Psychiatry Res. 2024;341:116169.
    >> Share

  125. SNELLEKSZ M, Dean B
    Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptors.
    Psychiatry Res. 2024;341:116156.
    >> Share

  126. MORO L, Sicotte R, Joober R, Malla A, et al
    Trajectories of suicidality during a 2-year early-intervention program for first-episode psychosis: A longitudinal study.
    Psychiatry Res. 2024;340:116148.
    >> Share

  127. COHEN S, Goldsmith DR, Ning CS, Addington J, et al
    Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosis.
    Psychiatry Res. 2024;341:116147.
    >> Share

  128. TSUI HKH, Luk SL, Hsiao J, Chan SKW, et al
    Facial emotion perception in individuals with clinical high risk for psychosis compared with healthy controls, first-episode psychosis, and in predicting psychosis transition: A systematic review and meta-analysis.
    Psychiatry Res. 2024;340:116143.
    >> Share

  129. GUZMAN A, Klein H, Keefe RS, Horan WP, et al
    Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls.
    Psychiatry Res. 2024;340:116121.
    >> Share

  130. GIANNOUCHOS TV, Ohsfeldt RL, Kum HC
    Trends and disparities in emergency department visits for schizophrenia spectrum disorders in Texas from 2019 to 2022.
    Psychiatry Res. 2024;340:116139.
    >> Share

  131. MENDEZ-VICTORIANO G, Zhu Y, Middleton F, Massa PT, et al
    Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with Schizophrenia and Bipolar Disorder.
    Psychiatry Res. 2024;340:116141.
    >> Share

  132. VITA G, Pollini D, Canozzi A, Papola D, et al
    Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis.
    Psychiatry Res. 2024;340:116124.
    >> Share

  133. VITA A, Nibbio G, Barlati S
    Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia.
    Psychiatry Res. 2024;340:116126.
    >> Share

    July 2024
  134. MAZZAROTTO F, Monteleone P, Minelli A, Mattevi S, et al
    Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis.
    Psychiatry Res. 2024;340:116107.
    >> Share

  135. GREVE AN, Hemager N, Mortensen EL, Gantriis DL, et al
    Comparing cognition in parents with schizophrenia or bipolar disorder and their 7-year-old offspring.
    Psychiatry Res. 2024;340:116112.
    >> Share

  136. LUCARINI V, Grice M, Wehrle S, Cangemi F, et al
    Language in interaction: turn-taking patterns in conversations involving individuals with schizophrenia.
    Psychiatry Res. 2024;339:116102.
    >> Share

  137. BLOSE BA, Silverstein SM, Stuart KV, Keane PA, et al
    Association between polygenic risk for schizophrenia and retinal morphology: A cross-sectional analysis of the United Kingdom Biobank.
    Psychiatry Res. 2024;339:116106.
    >> Share

  138. FEKIH-ROMDHANE F, Ghrissi F, Abassi B, Loch AA, et al
    Impulsivity as a predictor of clinical and psychological outcomes in a naturalistic prospective cohort of subjects at ultra-high risk (UHR) for psychosis from Tunisia.
    Psychiatry Res. 2024;340:116090.
    >> Share

  139. COFFMAN BA, Curtis M, Seebold D, Kocsis J, et al
    Long-latency auditory evoked response amplitudes at first episode of psychosis predict six-month recovery in positive symptom severity.
    Psychiatry Res. 2024;339:116094.
    >> Share

  140. LOURENCO PJDS, Bastos TCL, Pizarro AIN, Corredeira RMN, et al
    Feasibility and effectiveness of a 24-weeks outdoor exercise program on the physical and mental health of persons with schizophrenia.
    Psychiatry Res. 2024;339:116093.
    >> Share

  141. THELWELL ELR, Dunkerley L, Goodwin R, Giacco D, et al
    Effectiveness of online social networking interventions on social isolation and quality of life of people with psychosis: A systematic review.
    Psychiatry Res. 2024;339:116088.
    >> Share

  142. BIAN Y, Kawabata R, Enwright JF, Tsubomoto M, et al
    Expression of activity-regulated transcripts in pyramidal neurons across the cortical visuospatial working memory network in unaffected comparison individuals and individuals with schizophrenia.
    Psychiatry Res. 2024;339:116084.
    >> Share

  143. SCHUTZ A, Salahuddin NH, Priller J, Bighelli I, et al
    The role of control groups in non-pharmacological randomised controlled trials of treatment-resistant schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2024;339:116069.
    >> Share

  144. SIDDI S, Ochoa S, Laroi F, Lincoln TM, et al
    A cross-national investigation of psychosis-like experiences in five European countries included in the E-CLECTIC study: Psychometric challenges in studying their measurement.
    Psychiatry Res. 2024;339:116072.
    >> Share

  145. WANNAN CMJ, Eratne D, Santillo AF, Malpas C, et al
    Plasma neurofilament light protein is differentially associated with age in individuals with treatment-resistant schizophrenia and bipolar affective disorder compared to controls.
    Psychiatry Res. 2024;339:116073.
    >> Share

  146. WILTSCHKO M
    Is grammar affected in Schizophrenia?
    Psychiatry Res. 2024;339:116061.
    >> Share

  147. CHAN SKW, Pang TSW, Tsui HKH, Suen YN, et al
    Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia.
    Psychiatry Res. 2024;337:115985.
    >> Share

    June 2024
  148. MELISSA B, Sabrina G, Charles-Edouard G, Hind Z, et al
    Clinical characteristics associated with functioning trajectories following admission to a psychiatric institution: A prospective cohort study of individuals with psychosis.
    Psychiatry Res. 2024;339:116062.
    >> Share

  149. COLIJN MA
    Genetic testing in individuals experiencing psychosis: A practical guide for psychiatrists.
    Psychiatry Res. 2024;339:116052.
    >> Share

  150. ANDERSEN HG, DellaValle B, Bogehave H, Mogensen PB, et al
    Glycocalyx shedding patterns identifies antipsychotic-naive patients with first-episode psychosis.
    Psychiatry Res. 2024;339:116037.
    >> Share

  151. NADER G, Qureshi M, Chaudhary Z, Fischer CE, et al
    Effect of personality traits, psychological resilience and life adversities on lifetime violence trajectories: A novel classification model in schizophrenia.
    Psychiatry Res. 2024;339:116044.
    >> Share

  152. CHIEN WT, Chong YY, Bressington D, McMaster CW, et al
    A randomized controlled trial of an acceptance-based, insight-inducing medication adherence therapy (AIM-AT) for adults with early-stage psychosis.
    Psychiatry Res. 2024;339:116046.
    >> Share

  153. FERRARA M, Domenicano I, Marchi A, Zaffarami G, et al
    First episode psychoses in people over-35 years old: uncovering potential actionable targets for early intervention services.
    Psychiatry Res. 2024;339:116034.
    >> Share

  154. POUSA E, Brebion G, Lopez-Carrilero R, Ruiz AI, et al
    Predictors of clinical insight in first-episode psychosis: Different patterns in men and women.
    Psychiatry Res. 2024;339:116036.
    >> Share

  155. HOSTALET N, Gonzalez A, Salgado-Pineda P, Gonzalez-Colom R, et al
    Face-brain correlates as potential sex-specific biomarkers for schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;339:116027.
    >> Share

  156. BUCCI S, Berry N, Ainsworth J, Berry K, et al
    Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial.
    Psychiatry Res. 2024;339:116025.
    >> Share

  157. CHENG KY, Robinson N, Ploner A, Kuja-Halkola R, et al
    Impact of traumatic brain injury on risk for schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;339:115990.
    >> Share

  158. ROTELLA F, Falone A, Cassioli E, Mannucci E, et al
    The effect of differences in trial design on estimates of efficacy of olanzapine in randomized studies.
    Psychiatry Res. 2024;336:115895.
    >> Share

  159. MISHRA A, Maiti R, Ramasubbu MK, Srinivasan A, et al
    Evaluation of the pharmacodynamic interaction effect of augmentation agents with clozapine in patients with treatment-resistant schizophrenia: A simulation study of clinical data.
    Psychiatry Res. 2024;338:115989.
    >> Share

    May 2024
  160. WASTLER HM, Mengda Y, Pan X, Bornheimer LA, et al
    Trajectories of suicidal risk among individuals with first-episode psychosis: Relationship to recovery and symptoms.
    Psychiatry Res. 2024;338:115978.
    >> Share

  161. COLLINS M, Bartholomeusz C, Mei C, Kerr M, et al
    Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis.
    Psychiatry Res. 2024;337:115966.
    >> Share

  162. SANGIMINO M, Babbitt K, Lee HS, Park S, et al
    Bodily experiences of trauma and psychosis risk.
    Psychiatry Res. 2024;337:115961.
    >> Share

  163. OH H, Karcher NR, Li Verdugo J, Botello R, et al
    Ethno-racial disparities in psychosis-like experiences among students in higher education: Findings from the Healthy Minds Study 2020-2021.
    Psychiatry Res. 2024;337:115959.
    >> Share

  164. WU Y, Zhang CY, Zhang Y, Chen R, et al
    Genomic landscape and functional characterization of structural variations in schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;337:115929.
    >> Share

  165. BULDUK BK, Tortajada J, Valiente-Palleja A, Callado LF, et al
    High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls.
    Psychiatry Res. 2024;337:115928.
    >> Share

    April 2024
  166. GUO H, Zhong S, Lam ST, Wang N, et al
    Trends in violent offending among people with schizophrenia: A 10-year ecological study.
    Psychiatry Res. 2024;337:115935.
    >> Share

  167. BRADLEY ER, Portanova J, Woolley JD, Buck B, et al
    Quantifying abnormal emotion processing: A novel computational assessment method and application in schizophrenia.
    Psychiatry Res. 2024;336:115893.
    >> Share

  168. SMITH LC, Mateos AC, Due AS, Bergstrom J, et al
    Immersive virtual reality in the treatment of auditory hallucinations: A PRISMA scoping review.
    Psychiatry Res. 2024;334:115834.
    >> Share

    March 2024
  169. SPINAZZOLA E, Quattrone D, Quattrone A, Murray RM, et al
    The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use.
    Psychiatry Res. 2024;336:115869.
    >> Share

  170. HAMZEHPOUR L, Bohn T, Dutsch V, Jaspers L, et al
    From brain to body: exploring the connection between altered reward processing and physical fitness in schizophrenia.
    Psychiatry Res. 2024;335:115877.
    >> Share

  171. GALLEGO JA, McNamara RK, Blanco EA, Castaneda S, et al
    Evidence for cytokine dysregulation in schizophrenia spectrum disorders: A comparison of cerebrospinal fluid and blood samples.
    Psychiatry Res. 2024;335:115871.
    >> Share

  172. SEFIK E, Guest RM, Aberizk K, Espana R, et al
    Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
    Psychiatry Res. 2024;335:115867.
    >> Share

  173. SETHI S, Wakeham D, Ketter T, Hooshmand F, et al
    Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.
    Psychiatry Res. 2024;335:115866.
    >> Share

  174. YANG H, Zhu D, Liu Y, Xu Z, et al
    Employing graph attention networks to decode psycho-metabolic interactions in Schizophrenia.
    Psychiatry Res. 2024;335:115841.
    >> Share

  175. KISHI T, Citrome L, Sakuma K, Iwata N, et al
    A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.
    Psychiatry Res. 2024;333:115761.
    >> Share

    February 2024
  176. GORORA ME, Dalkner N, Moore RC, Depp CA, et al
    A meta-cognitive Wisconsin Card Sorting Test in people with schizophrenia and bipolar disorder: Self-assessment of sorting performance.
    Psychiatry Res. 2024;334:115831.
    >> Share

  177. QIN K, Yu Y, Cai H, Li J, et al
    Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials.
    Psychiatry Res. 2024;334:115808.
    >> Share

  178. KIKUCHI Y, Komatsu H, Otsuka Y, Ito F, et al
    Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
    Psychiatry Res. 2024;334:115810.
    >> Share

  179. GOODING DC, Mohrbacher DA, Umucu E, Van Hulle CA, et al
    Ethnoracialized group differences in attitudes and knowledge about schizophrenia and willingness to engage in biomarker research: The UBIGR Study.
    Psychiatry Res. 2024;334:115776.
    >> Share

  180. HYATT AS, Mulvaney-Day N, Chow CM, Cook BL, et al
    Association between electronic nicotine product use and subsequent first episode psychosis.
    Psychiatry Res. 2024;334:115785.
    >> Share

  181. KWAK PP, Ibarra C, Hernandez A, Carrasco J, et al
    Differences in metabolic biomarkers in people with schizophrenia who are of Mexican descent compared to non-Hispanic whites.
    Psychiatry Res. 2024;334:115788.
    >> Share

  182. QUIRINO AHA, da Rocha MEC, Andrade AGM, E Souza FGM, et al
    The demonstrated association: Cannabis use and onset of psychosis in the study by Medeiros et al., refuting the reverse notion.
    Psychiatry Res. 2024;334:115771.
    >> Share

    January 2024
  183. HE R, Palominos C, Zhang H, Alonso-Sanchez MF, et al
    Navigating the semantic space: Unraveling the structure of meaning in psychosis using different computational language models.
    Psychiatry Res. 2024;333:115752.
    >> Share

  184. KOS C, Bais L, Klaasen N, Opmeer E, et al
    Effects of right prefrontal theta-burst transcranial magnetic stimulation or transcranial direct current stimulation on apathy in patients with schizophrenia: A multicenter RCT.
    Psychiatry Res. 2024;333:115743.
    >> Share

  185. YI S, Wang Q, Wang W, Hong C, et al
    Efficacy of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms and cognitive functioning in schizophrenia: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2024;333:115728.
    >> Share

  186. TOUMAIAN M, Covanis P, Mantas A, Karantinos T, et al
    Multisensory integration deficits in Schizophrenia and Autism evidenced in behaviour but not event related potentials.
    Psychiatry Res. 2024;332:115727.
    >> Share

  187. PROHENS L, Rodriguez N, Segura AG, Martinez-Pinteno A, et al
    Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
    Psychiatry Res. 2024;332:115722.
    >> Share

  188. JEROME L, Matanov A, Bird V, Priebe S, et al
    Comparison of subjective quality of life domains in schizophrenia, mood, and anxiety disorders; an individual patient data meta-analysis.
    Psychiatry Res. 2024;332:115707.
    >> Share

  189. CHU RST, Chong RCH, Chang DHH, Shan Leung AL, et al
    The risk of stroke and post-stroke mortality in people with schizophrenia: A systematic review and meta-analysis study.
    Psychiatry Res. 2024;332:115713.
    >> Share

  190. SETIEN-SUERO E, Ayesa-Arriola R, Pena J, Ojeda N, et al
    Premorbid adjustment as predictor of long-term functionality: Findings from a 10-year follow-up study in the PAFIP-cohort.
    Psychiatry Res. 2024;331:115674.
    >> Share

  191. MASTELLARI T, Saint-Dizier C, Fovet T, Geoffroy PA, et al
    Exploring seasonality in catatonia diagnosis: Evidence from a large-scale population study.
    Psychiatry Res. 2024;331:115652.
    >> Share

    December 2023
  192. WANG Y, Zhang X
    The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy: Immune-inflammation in ECT for schizophrenia.
    Psychiatry Res. 2023;332:115708.
    >> Share

  193. VGONTZAS AN, Paschalidou A, Simos PG, Anastasaki M, et al
    Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder.
    Psychiatry Res. 2023;332:115676.
    >> Share

  194. TORREY EF
    Did the human genome project affect research on Schizophrenia?
    Psychiatry Res. 2023;333:115691.
    >> Share

  195. KIM WS, Shen J, Tsogt U, Odkhuu S, et al
    Altered thalamic volumes and functional connectivity in the recovered patients with psychosis.
    Psychiatry Res. 2023;331:115688.
    >> Share

  196. ZHOU D, Xie H, Chen L, Zhu Z, et al
    The cognitive improvement in patients with schizophrenia following low-intensity repetitive transcranial magnetic stimulation could last for 6 months: A randomized controlled trial.
    Psychiatry Res. 2023;332:115672.
    >> Share

  197. CHEN Y, Zhang L, Sun Y, Wang W, et al
    Prevalence of constipation in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;331:115659.
    >> Share

  198. DE MEDEIROS MW, Andrade JC, Haddad NM, Mendonca M, et al
    Cannabis use influences disorganized symptoms severity but not transition in a cohort of non-help-seeking individuals at-risk for psychosis from Sao Paulo, Brazil.
    Psychiatry Res. 2023;331:115665.
    >> Share

  199. DEAN B, Duce J, Li QX, Masters CL, et al
    Lower levels of soluble beta-amyloid precursor protein, but not beta-amyloid, in the frontal cortex in schizophrenia.
    Psychiatry Res. 2023;331:115656.
    >> Share

  200. FENG XZ, Li Z, Li ZY, Wang K, et al
    Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;332:115637.
    >> Share

  201. VINOGRADOV S
    Harnessing neuroplasticity.
    Psychiatry Res. 2023;330:115607.
    >> Share

  202. STAFFORD E, Jakob S, Gur RE, Corcoran CM, et al
    Securing direct stakeholder feedback to inform clinical research in serious mental illness: Results of a patient and family perspectives survey.
    Psychiatry Res. 2023;330:115574.
    >> Share

    November 2023
  203. GROENING JM, Denton E, Parvaiz R, Brunet DL, et al
    A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2023;331:115626.
    >> Share

  204. LAMANNA-RAMA N, Romero-Miguel D, Casquero-Veiga M, MacDowell KS, et al
    THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.
    Psychiatry Res. 2023;331:115643.
    >> Share

  205. WEI Z, Wang Y, Hu L, Wang Y, et al
    Incidence, prevalence, and mortality of schizophrenia from 2016 to 2020 in Shandong, China.
    Psychiatry Res. 2023;331:115612.
    >> Share

  206. LEE J, Xue X, Au E, McIntyre WB, et al
    Central insulin dysregulation in antipsychotic-naive first-episode psychosis: In silico exploration of gene expression signatures.
    Psychiatry Res. 2023;331:115636.
    >> Share

  207. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    20-Year trajectories of six psychopathological dimensions in patients with first-episode psychosis: Could they be predicted?
    Psychiatry Res. 2023;331:115614.
    >> Share

  208. HU Q, Jiao X, Zhou J, Tang Y, et al
    Low-frequency repetitive transcranial magnetic stimulation over the right orbitofrontal cortex for patients with first-episode schizophrenia: A randomized, double-blind, sham-controlled trial.
    Psychiatry Res. 2023;330:115600.
    >> Share

  209. BOGE K, Hallford DJ, Pillny M
    Mindfulness, psychological flexibility and their relationship with psychopathology in persons with schizophrenia-spectrum-disorders and healthy controls - A multicenter cross-sectional study.
    Psychiatry Res. 2023;330:115591.
    >> Share

  210. DAZZAN P
    Disentangling psychosis: The challenges of informing precision medicine for what is not a single disorder.
    Psychiatry Res. 2023;330:115596.
    >> Share

  211. BERNARDIN F, Gauld C, Martin VP, Laprevote V, et al
    The 68 symptoms of the clinical high risk for psychosis: Low similarity among fourteen screening questionnaires.
    Psychiatry Res. 2023;330:115592.
    >> Share

  212. CORNBLATT BA, McFarlane WR, Carrion RE
    Authors' reply to comments on: Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;330:115594.
    >> Share

  213. KIRSHENBAUM AP, Sofis MJ, Slade M
    Response to recreational cannabis use over time in individuals at clinical high risk for psychosis: lack of associations with symptom, neurocognitive, functioning, and treatment patterns by Carrion et al., 2023.
    Psychiatry Res. 2023;330:115589.
    >> Share

  214. PARK S
    Schizophrenia in the mind, the brain and the body.
    Psychiatry Res. 2023;329:115547.
    >> Share

    October 2023
  215. BIRONG CHEN, Tan XW, Tor PC
    The impact of the number of previous illness episodes on early response to electroconvulsive therapy (ECT) in psychosis, mania, depression, psychotic depression, and catatonia: A naturalistic transdiagnostic analysis.
    Psychiatry Res. 2023;330:115580.
    >> Share

  216. KIM HK, Goncalves VF, Husain MI, Muller DJ, et al
    Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia.
    Psychiatry Res. 2023;330:115563.
    >> Share

  217. LIN CH, Huang CJ, Lin TC, Chan HY, et al
    Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
    Psychiatry Res. 2023;330:115575.
    >> Share

  218. WANG P, Jiang Y, Hoptman MJ, Li Y, et al
    Structural-functional connectivity deficits of callosal-white matter-cortical circuits in schizophrenia.
    Psychiatry Res. 2023;330:115559.
    >> Share

  219. VAN DER TUIN S, Booij SH, Muller MK, van den Berg D, et al
    The added value of daily diary data in 1- and 3-year prediction of psychopathology and psychotic experiences in individuals at risk for psychosis.
    Psychiatry Res. 2023;329:115546.
    >> Share

  220. HASSAN L, Eisner E, Berry K, Emsley R, et al
    User engagement in a randomised controlled trial for a digital health intervention for early psychosis (Actissist 2.0 trial).
    Psychiatry Res. 2023;329:115536.
    >> Share

  221. SCHLIEF M, Rich N, Rains LS, Baldwin H, et al
    Ethnic differences in receipt of psychological interventions in Early Intervention in Psychosis services in England - a cross-sectional study.
    Psychiatry Res. 2023;330:115529.
    >> Share

  222. ZHANG T, Xu L, Wei Y, Tang X, et al
    Duration of untreated prodromal psychosis among individuals with clinical high risk for psychosis.
    Psychiatry Res. 2023;329:115522.
    >> Share

    September 2023
  223. SAMPEDRO A, Pena J, Sanchez P, Ibarretxe-Bilbao N, et al
    Moderators of functional improvement after integrative cognitive remediation in schizophrenia: Toward a personalized treatment approach.
    Psychiatry Res. 2023;329:115495.
    >> Share

  224. HUI CLM, Wong CCL, Chan EWT, Suen YN, et al
    COVID-19 exposure and psychosis: A comparison of clinical, functional, and cognitive profiles in remitted patients with psychosis.
    Psychiatry Res. 2023;328:115487.
    >> Share

  225. CAMPRODON-BOADAS P, De la Serna E, Plana MT, Flamarique I, et al
    Delusional beliefs in adolescents with anorexia nervosa, obsessive-compulsive disorder, or first-episode psychosis: A comparative study.
    Psychiatry Res. 2023;328:115490.
    >> Share

  226. BALDINI V, Stefano RD, Rindi LV, Ahmed AO, et al
    Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Psychiatry Res. 2023;329:115488.
    >> Share

  227. GEBREEGZIABHERE Y, Habatmu K, Cella M, Alem A, et al
    Introducing an interview-based cognitive assessment tool for people with Schizophrenia in Ethiopia.
    Psychiatry Res. 2023;328:115474.
    >> Share

  228. SANCHEZ-TORRES AM, Garcia de Jalon E, Gil-Berrozpe GJ, Peralta V, et al
    Cognitive intraindividual variability, cognitive impairment and psychosocial functioning in first-episode psychosis patients.
    Psychiatry Res. 2023;328:115473.
    >> Share

  229. FORDHAM E, Gao CX, Filia K, O'Donoghue B, et al
    Social disadvantage in early psychosis and its effect on clinical presentation and service access, engagement and use.
    Psychiatry Res. 2023;328:115478.
    >> Share

  230. MAURUS I, Roell L, Lembeck M, Papazova I, et al
    Exercise as an add-on treatment in individuals with schizophrenia: Results from a large multicenter randomized controlled trial.
    Psychiatry Res. 2023;328:115480.
    >> Share

  231. INCHAUSTI L, Gorostiza I, Gonzalez Torres MA, Oraa R, et al
    The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use.
    Psychiatry Res. 2023;328:115475.
    >> Share

  232. FANG X, Gao C, Wu W, Hu X, et al
    The role of the gut microbiome in weight-gain in schizophrenia patients treated with atypical antipsychotics: Evidence based on altered composition and function in a cross-sectional study.
    Psychiatry Res. 2023;328:115463.
    >> Share

  233. ZHANG J, Yang Y, Liu T, Shi Z, et al
    Functional connectivity in people at clinical and familial high risk for schizophrenia.
    Psychiatry Res. 2023;328:115464.
    >> Share

  234. SMITH ECC, Au E, Pereira S, Sharma E, et al
    Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review.
    Psychiatry Res. 2023;328:115472.
    >> Share

  235. LUCKHOFF HK, Asmal L, Smit R, Phahladira L, et al
    Sex, gender, and outcome in first-episode psychosis: The role of premorbid functioning.
    Psychiatry Res. 2023;328:115460.
    >> Share

  236. SEGAL SP, Rimes L, Badran L
    Crime and victimization outcomes following civil rights limits to the use of compulsory treatment.
    Psychiatry Res. 2023;327:115377.
    >> Share

  237. JOSHI YB, Gonzalez CE, Molina JL, MacDonald LR, et al
    Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders.
    Psychiatry Res. 2023;327:115215.
    >> Share

  238. XIE Y, Guan M, Wang Z, Ma Z, et al
    Alterations in brain connectivity patterns in schizophrenia patients with auditory verbal hallucinations during low frequency repetitive transcranial magnetic stimulation.
    Psychiatry Res. 2023;328:115457.
    >> Share

    August 2023
  239. CARRION RE, Auther AM, McLaughlin D, Adelsheim S, et al
    Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;328:115420.
    >> Share

  240. JOHANSSON M, Hjarthag F, Helldin L
    Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in schizophrenia.
    Psychiatry Res. 2023;328:115421.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016